Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2015 (2015), Article ID 864271, 6 pages
http://dx.doi.org/10.1155/2015/864271
Clinical Study

Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis

1Department of Infectious Diseases, RDT Bathalapalli Hospital, Kadiri Road, Bathalapalli 515661, India
2Department of Microbiology, RDT Bathalapalli Hospital, Kadiri Road, Bathalapalli 515661, India

Received 4 June 2015; Revised 28 August 2015; Accepted 30 August 2015

Academic Editor: Marcel Tanner

Copyright © 2015 Gerardo Alvarez-Uria et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Park, K. A. Wannemuehler, B. J. Marston, N. Govender, P. G. Pappas, and T. M. Chiller, “Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS,” AIDS, vol. 23, no. 4, pp. 525–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Sloan and V. Parris, “Cryptococcal meningitis: epidemiology and therapeutic options,” Clinical Epidemiology, vol. 6, no. 1, pp. 169–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, “Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children,” December 2011, http://www.who.int/hiv/pub/cryptococcal_disease2011/en/.
  4. R. Rajasingham, M. A. Rolfes, K. E. Birkenkamp, D. B. Meya, and D. R. Boulware, “Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis,” PLoS Medicine, vol. 9, no. 9, Article ID e1001316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Bicanic, R. Wood, G. Meintjes et al., “High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial,” Clinical Infectious Diseases, vol. 47, no. 1, pp. 123–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Bicanic, G. Meintjes, R. Wood et al., “Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole,” Clinical Infectious Diseases, vol. 45, no. 1, pp. 76–80, 2007. View at Publisher · View at Google Scholar
  7. A. T. Jackson, J. C. Nussbaum, J. Phulusa et al., “A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis,” AIDS, vol. 26, no. 11, pp. 1363–1370, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Strenger, A. Meinitzer, J. Donnerer et al., “Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 9, pp. 2522–2526, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kethireddy and D. Andes, “CNS pharmacokinetics of antifungal agents,” Expert Opinion on Drug Metabolism and Toxicology, vol. 3, no. 4, pp. 573–581, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Fang, Z. Fa, and W. Liao, “Epidemiology of Cryptococcus and cryptococcosis in China,” Fungal Genetics and Biology, vol. 78, pp. 7–15, 2015. View at Publisher · View at Google Scholar
  11. C. Yuchong, C. Jianghan, W. Hai, and G. Julin, “Lumbar puncture drainage with intrathecal injection of amphotericin B for control of cryptococcal meningitis,” Mycoses, vol. 54, no. 4, pp. e248–e251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. N. Galgiani, N. M. Ampel, J. E. Blair et al., “Coccidioidomycosis,” Clinical Infectious Diseases, vol. 41, no. 9, pp. 1217–1223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. V. Clemons, R. A. Sobel, P. L. Williams, and D. A. Stevens, “Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 2, pp. 612–615, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Mete, N. Saltoglu, E. Vanli et al., “Simultaneous cryptococcal and tuberculous meningitis in a patient with systemic lupus erythematosus,” Journal of Microbiology, Immunology and Infection, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. B. L. Grannan, V. Yanamadala, A. S. Venteicher, B. P. Walcott, and J. C. Barr, “Use of external ventriculostomy and intrathecal anti-fungal treatment in cerebral mucormycotic abscess,” Journal of Clinical Neuroscience, vol. 21, no. 10, pp. 1819–1821, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Capilla, A. Flavia, E. Mayayo, and J. Guarro, “Efficacy of intrathecal liposomal amphotericin B plus oral posaconazole in the treatment of acute meningeal cryptococcosis in a murine model,” International Journal of Antimicrobial Agents, vol. 42, no. 3, pp. 282–283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. F. Gazzoni, J. Capilla, E. Mayayo, and J. Guarro, “Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis,” International Journal of Antimicrobial Agents, vol. 39, no. 3, pp. 223–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Office of the Registrar General & Census Commissioner, Census of India, New Delhi, India, 2011.
  19. G. Alvarez-Uria, M. Midde, R. Pakam, and P. K. Naik, “Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India,” Infectious Disease Reports, vol. 4, no. 1, article e19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Alvarez-Uria, R. Pakam, M. Midde, and P. K. Naik, “Entry, retention, and virological suppression in an HIV cohort study in India: description of the cascade of care and implications for reducing HIV-related mortality in low- and middle-income countries,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2013, Article ID 384805, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Alvarez-Uria, P. K. Naik, R. Pakam, L. Bachu, and M. Midde, “Natural history and factors associated with early and delayed mortality in HIV-infected patients treated of tuberculosis under directly observed treatment short-course strategy: a prospective cohort study in India,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 502012, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sundar, K. Pandey, C. P. Thakur et al., “Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study,” PLoS Neglected Tropical Diseases, vol. 8, no. 9, article e3169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Sundar, J. Chakravarty, D. Agarwal, A. Shah, N. Agrawal, and M. Rai, “Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar,” Tropical Medicine & International Health, vol. 13, no. 9, pp. 1208–1212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. G. Kleinbaum and M. Klein, Survival Analysis, a Self-Learning Text, Springer, 2nd edition, 2005.
  25. P. Royston and P. C. Lambert, Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model, StataCorp, 2011, https://ideas.repec.org/b/tsj/spbook/fpsaus.html.
  26. J. N. Jarvis, T. Bicanic, A. Loyse et al., “Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes,” Clinical Infectious Diseases, vol. 58, no. 5, pp. 736–745, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C. K. Muzoora, T. Kabanda, G. Ortu et al., “Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis,” Journal of Infection, vol. 64, no. 1, pp. 76–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Perfect, W. E. Dismukes, F. Dromer et al., “Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America,” Clinical Infectious Diseases, vol. 50, no. 3, pp. 291–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Rolfes, K. H. Hullsiek, J. Rhein et al., “The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis,” Clinical Infectious Diseases, vol. 59, no. 11, pp. 1607–1614, 2014. View at Publisher · View at Google Scholar
  30. K. T. Thakur, K. Mateyo, L. Hachaambwa et al., “Lumbar puncture refusal in sub-Saharan Africa: a call for further understanding and intervention,” Neurology, vol. 84, no. 19, pp. 1988–1990, 2015. View at Publisher · View at Google Scholar
  31. A. Kambugu, D. B. Meya, J. Rhein et al., “Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy,” Clinical Infectious Diseases, vol. 46, no. 11, pp. 1694–1701, 2008. View at Publisher · View at Google Scholar · View at Scopus